跳至主要内容
临床试验/NL-OMON53722
NL-OMON53722招募中不适用

Role of the central brain clock in the pathophysiology of insulin resistance - Brain Clock and Insulin Resistance

Amsterdam UMC0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • Group 1: obese people with normal insulin sensitivity
  • age 25-65 years
  • fasting plasma insulin <=62 pmol/L
  • fasting plasma glucose <5.6 mmol/L
  • HOMA-IR <= 4.5
  • Group 2: obese people with insulin resistance
  • age 25-65 years
  • fasting plasma insulin >62 pmol/L
  • fasting plasma glucose >=5.6 mmol/L
  • not fulfilling the ADA criteria for type 2 DM
  • Group 3: obese subjects with overt type 2 DM
  • age 25-65 years
  • diagnosis type 2 DM according to ADA criteria

排除标准

  • An extreme chronotype (midpoint of sleep on free days (MSFsc) before 2:00 or
  • after 6:00).
  • Active psychiatric disorder (including circadian rhythm sleep disorder) as
  • defined in DSM 5
  • Disorders of the central nervous system (Early-onset dementia, stroke,
  • epilepsy, Parkinson*s disease, brain tumour)
  • Severe visual impairment (WHO classification)
  • Shift workers
  • Crossing > 2 time zones in the 3 months before the study
  • Patients with type 2 DM receiving insulin treatment or GLP-1 agonists
  • MRI safety and contraindications
  • o The presence of MRI-incompatible metal implants or devices:
  • o Claustrophobia
  • o Pregnancy
  • o Waist circumference or shoulder circumference >155 cm
  • o Body weight > 200 kg
  • o Inability to walk up a staircase independently

研究者

发起方
Amsterdam UMC

相似试验